These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 6686774

  • 1. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
    [Abstract] [Full Text] [Related]

  • 2. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG, Hutt V, Klör HU, Ditschuneit H.
    Artery; 1980; 8(6):519-29. PubMed ID: 7259531
    [Abstract] [Full Text] [Related]

  • 5. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [Abstract] [Full Text] [Related]

  • 6. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R.
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [Abstract] [Full Text] [Related]

  • 7. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V, Klör HU, Wechsler JG, Ditschuneit H.
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [Abstract] [Full Text] [Related]

  • 8. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS.
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [Abstract] [Full Text] [Related]

  • 9. [Treatment with high-dose beta-pyridylcarbinol: results in patients with hypercholesterinemia].
    Mordasini R, Schlumpf E, Nobile PC, Brun del Re G, Riva G.
    Schweiz Med Wochenschr; 1978 Apr 08; 108(14):533-8. PubMed ID: 635510
    [Abstract] [Full Text] [Related]

  • 10. Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
    Shinomiya M, Ishikawa Y, Shirai K, Saito Y, Yoshida S.
    Arzneimittelforschung; 1987 Sep 08; 37(9):1069-71. PubMed ID: 3435604
    [Abstract] [Full Text] [Related]

  • 11. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 12. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
    Jones GJ, Hewitt D, Godin GJ, Breckenridge WC, Bird J, Mishkel MA, Steiner G, Little JA.
    Can Med Assoc J; 1980 Jan 12; 122(1):37-8, 40-6. PubMed ID: 7363194
    [Abstract] [Full Text] [Related]

  • 13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Jan 12; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD.
    Am J Cardiol; 2005 Nov 01; 96(9):1266-72. PubMed ID: 16253595
    [Abstract] [Full Text] [Related]

  • 16. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H, Bojanovski D.
    Artery; 1980 Nov 01; 8(2):171-8. PubMed ID: 7458684
    [Abstract] [Full Text] [Related]

  • 17. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov 01; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 19. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T, de Gallegos CN, Proudler A, Parker K, Anayaoku V, Bannister P, Venkatesan S, Johnston DG.
    Metabolism; 2003 Jan 01; 52(1):50-9. PubMed ID: 12524662
    [Abstract] [Full Text] [Related]

  • 20. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K, Kiessling H.
    Artery; 1981 Jan 01; 9(6):456-76. PubMed ID: 7337554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.